help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 31, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1893
A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/4/1535    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHARMANDARI, E.
Right arrow Articles by CHROUSOS, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHARMANDARI, E.
Right arrow Articles by CHROUSOS, G. P.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
Medline Plus Health Information
*Steroids

Submitted on August 23, 2005
Accepted on January 20, 2006

Functional Characterization of the Natural Human Glucocorticoid Receptor (hgr) Mutants hgr{alpha}r477h and hgr{alpha}g679s Associated with Generalized Glucocorticoid Resistance

EVANGELIA CHARMANDARI*, TOMOSHIGE KINO, TAKAMASA ICHIJO, KEITH ZACHMAN, ANTON ALATSATIANOS, and GEORGE P. CHROUSOS

Pediatric Endocrinology Section, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, U.S.A.

* To whom correspondence should be addressed. E-mail: charmane{at}mail.nih.gov.

Background: Glucocorticoid resistance is often due to mutations in the human glucocorticoid receptor {alpha} (hGR{alpha}) gene, which impair one or more of hGR{alpha}'s functions. We investigated the molecular mechanisms through which two previously described mutant receptors, hGR{alpha}R477H and hGR{alpha}G679S, with amino acid substitutions in the DNA- and ligand-binding domains, respectively, affect glucocorticoid signal transduction.

Methods and Results: In transient transfection assays, hGR{alpha}R477H displayed no transcriptional activity, while hGR{alpha}G679S showed a 55% reduction in its ability to stimulate the transcription of the glucocorticoid-responsive MMTV promoter in response to dexamethasone compared with the wild-type hGR{alpha}. Neither hGR{alpha}R477H nor hGR{alpha}G679S exerted a dominant negative effect upon the wild-type receptor. Dexamethasone binding assays showed that hGR{alpha}R477H preserved normal affinity for the ligand, whereas hGR{alpha}G679S displayed a 2-fold reduction compared with hGR{alpha}. Nuclear translocation studies confirmed predominantly cytoplasmic localization of the mutant receptors in the absence of ligand. Exposure to dexamethasone resulted in slower translocation of hGR{alpha}R477H (25 min) and hGR{alpha}G679S (30 min) into the nucleus than the wild-type hGR{alpha} (12 min). In ChIP assays in cells stably transfected with the MMTV promoter, hGR{alpha}R477H did not bind to GREs, whereas hGR{alpha}G679S preserved its ability to bind to GREs. Finally, in GST pull-down assays, hGR{alpha}G679S interacted with the GRIP1 coactivator in vitro only through its activation function (AF)-1, unlike the hGR{alpha}R477H and hGR{alpha}, which interacted with GRIP1 through both their AF-1 and AF-2.

Conclusions: The natural mutants hGR{alpha}R477H and hGR{alpha}G679S cause generalized glucocorticoid resistance by affecting different functions of the glucocorticoid receptor, which span the cascade of the hGR signaling system.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos
Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Raef, E. Y Baitei, M. Zou, and Y. Shi
Genotype-phenotype correlation in a family with primary cortisol resistance: possible modulating effect of the ER22/23EK polymorphism.
Eur. J. Endocrinol., April 1, 2008; 158(4): 577 - 582.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Charmandari, T. Kino, T. Ichijo, W. Jubiz, L. Mejia, K. Zachman, and G. P. Chrousos
A Novel Point Mutation in Helix 11 of the Ligand-Binding Domain of the Human Glucocorticoid Receptor Gene Causing Generalized Glucocorticoid Resistance
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3986 - 3990.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society